DICE Therapeutics, Inc.
DICE Therapeutics, Inc. (DICE) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
dice · stock forecast · 10 analysts (3M) · FMP · updated Mar 26, 2024
Analyst Rating & Consensus
Based on 10 Wall Street analysts in the past 3 months
Buy
10 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$60.00
Consensus
$60.00
+26.2% upside
Low
$60.00
Median: $60 · Last Close: $47.55
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · DICE · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-06-26 | Needham | Downgrade ↓ | Buy→Hold |
| 2023-06-25 | Needham | Downgrade ↓ | Buy→Hold |
| 2023-06-21 | Canaccord Genuity | Downgrade ↓ | Buy→Hold |
| 2023-06-21 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2023-06-20 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2023-06-20 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2023-06-20 | Canaccord Genuity | Downgrade ↓ | Buy→Hold |
| 2023-06-20 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2023-06-19 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2023-06-19 | Canaccord Genuity | Downgrade ↓ | Buy→Hold |
Wall Street analysts have recently issued updated ratings on DICE Therapeutics, Inc. (DICE) stock. Of the recent 30 rating actions, 0 were upgrades and 9 were downgrades. 10 analysts currently cover DICE.
Analyst Recommendation Trends
DICE analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
—
Revenue Next Year
—
EPS This Year
—
EPS Next Year
—
EPS ForecastReported vs Estimated
Analysts forecast DICE EPS of $— for the current fiscal year, based on estimates from 0 analysts. The DICE revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The DICE stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus DICE price target is $60.00 (+26.2% upside), with an analyst consensus of Buy.
DICE Therapeutics, Inc. trades on NASDAQ under the ticker DICE. The DICE stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
DICE forecast · 8 questionsAccording to 10 Wall Street analysts, the average 12-month DICE price target is $60.00, with a high forecast of $60.00 and a low of $60.00. The median price target is shown in the chart above when available. This implies +26.2% potential upside from the current price of $47.55.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.